Kyriakidis G, Barletta M
J Pharm Sci. 1980 Apr;69(4):447-51. doi: 10.1002/jps.2600690422.
To obviate the myocardial depressant action of propranolol, the use of this drug in combination with a positive inotropic agent, mannitol, was studied in the ischemic heart of the dog. Mannitol (25%) administered prior to propranolol augmented myocardial contractility, as shown by an upward shift of the relationship between the pressure change with time and the mean left atrial pressure. Subsequent administration of propranolol did not offset the positive inotropic response to mannitol whereas it markedly reduced the heart rate from a control ischemic value of 127.8 +/- 3.4 to 109 +/- 4.0 beats/min. The myocardial oxygen requirement, as determined by the tension-time index per minute, decreased 26.3 +/- 1.2% below the control ischemic value. These findings suggest that hypertonic mannitol augments contractility in the ischemic failing heart while sustaining the desirable negative chronotropic action of propranolol. This procedure may potentiate the beneficial effects of propranolol on the myocardial oxygen balance and serve as an effective therapeutic modality in the control of acute irreversible ischemia.
为消除普萘洛尔的心肌抑制作用,在犬的缺血心脏中研究了该药与正性肌力药物甘露醇联合使用的情况。在给予普萘洛尔之前给予甘露醇(25%)可增强心肌收缩力,这表现为压力随时间变化与平均左心房压力之间的关系向上移位。随后给予普萘洛尔并未抵消对甘露醇的正性肌力反应,而它却使心率从缺血对照值127.8±3.4显著降至109±4.0次/分钟。由每分钟张力 - 时间指数所确定的心肌需氧量,比缺血对照值降低了26.3±1.2%。这些发现表明,高渗甘露醇可增强缺血性衰竭心脏的收缩力,同时维持普萘洛尔所需的负性变时作用。该方法可能会增强普萘洛尔对心肌氧平衡的有益作用,并可作为控制急性不可逆缺血的一种有效治疗方式。